Prof. Dr. Zeina Malek
He began his academic career at the University of Damascus Faculty of Pharmacy, where he earned both his bachelor's degree and postgraduate qualifications in pharmaceutical manufacturing. He later obtained a master’s degree from Paris Descartes University (Paris 5) and a PhD from Martin Luther University Halle-Wittenberg in Germany, where his dissertation focused on the development of metformin tablets designed to mimic the circadian variation of blood glucose levels.
He possesses more than 20 years of experience in the development of innovative pharmaceutical dosage forms, pharmaceutical nanotechnology, and the design of novel antimicrobial agents, in addition to molecular modeling and pharmaceutical data analysis.
He worked at the Pharmacovigilance Center in Paris in collaboration with the World Health Organization, contributing to the development of causality assessment methods for adverse drug reactions. He also served as Production Manager at Pamela Pharmaceutical Industries, where he led automation initiatives and the development of new pharmaceutical formulations. Since 2005, he has dedicated his efforts as a researcher at the Arab International University, leading projects focused on the use of nanotechnology in drug development, the design of innovative antibiotics, and the conduct of clinical and bioequivalence studies. In 2017, he was appointed Vice Dean of the Faculty of Pharmacy for Scientific Affairs at the university, combining academic leadership with applied research.
In addition to his professional expertise, he has an extensive record of innovation. He was granted a European patent for an innovative metformin-based formulation for diabetes treatment, as well as a French patent for a multipurpose spectroscopic measurement system based on image analysis. He has also published numerous studies in prestigious international scientific journals covering a wide range of topics, from pharmaceutical dosage form development to toxicology and pharmacoepidemiology studies, in addition to recent research on COVID-19 vaccines and inflammatory markers among university students.
